Dr. Reddy's Laboratories Limited (DRREDDY) — Annual Report Announcement
Dr. Reddy's Laboratories disclosed its FY2026 consolidated financial statements filed with the SEC on May 30, 2026, reporting results under IFRS for the year ended March 31, 2026. The filing includes the full annual report accessible on the company website. **₹12,500 crores** revenue and **₹2,100 crores** net profit were highlighted in the document. The company reaffirmed its strategic focus on global expansion and R&D investment. **₹500 crores** capital expenditure is planned for FY2027. No dividend was declared for the fiscal year. The filing underscores compliance with SEBI regulations and enhances transparency for global investors.
📄 View Original Announcement (PDF)
About Dr. Reddy's Laboratories Limited (DRREDDY)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.